﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2026-08-17T14:51:03-04:00</ReturnTs>
    <TaxPeriodEndDt>2025-09-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>460952065</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>BOUNTIFUL PEAK ADVISORS</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1564 SOUTH 500 WEST SUITE 201</AddressLine1Txt>
        <CityNm>BOUNTIFUL</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>840107400</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-10-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>237088244</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>ACADEMY OF CLINICAL LABORATORY</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>PHYSICIANS AND SCIENTISTS</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ACAD</BusinessNameControlTxt>
      <PhoneNum>8015832787</PhoneNum>
      <USAddress>
        <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
        <CityNm>SALT LAKE CITY</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>841081221</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>TATIANA YUZYUK PHD</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>8015832787</PhoneNum>
      <SignatureDt>2026-08-12</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>JUSTIN R SHAW CPA CFE CGMA</PreparerPersonNm>
      <PTIN>P00081558</PTIN>
      <PhoneNum>8012943155</PhoneNum>
      <PreparationDt>2026-08-17</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="5">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc4">
      <PrincipalOfficerNm>TATIANA YUZYUK PHD</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
        <CityNm>SALT LAKE CITY</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>841081221</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>93017</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ACLPS.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1994</FormationYr>
      <LegalDomicileStateCd>UT</LegalDomicileStateCd>
      <ActivityOrMissionDesc>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>6</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>6</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>2154</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1127</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>39450</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>44500</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>40276</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>47390</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>81880</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>93017</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>25300</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>17800</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>62495</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>50556</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>87795</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>68356</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-5915</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>24661</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>1687016</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>1828923</TotalAssetsEOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>1687016</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>1828923</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>59718</ExpenseAmt>
      <GrantAmt>17800</GrantAmt>
      <RevenueAmt>44500</RevenueAmt>
      <Desc>DURING THE YEAR THAT ENDED SEPTEMBER 30, 2025, THE ACADEMY PROVIDED SERVICES TO APPROXIMATELY 400 ACTIVE MEMBERS AND 220 ASSOCIATE MEMBERS. MORE THAN 200 INDIVIDUALS ATTENDED THE ACLPS ANNUAL MEETING ("LAB MEDICINE") IN ATLANTA, GA, ON MAY 29-31, 2025. THE MEETING WAS HOSTED BY EMORY UNIVERSITY. OVER THE THREE DAYS, CONFERENCE ATTENDEES ENJOYED SCIENTIFIC SESSIONS, THE AWARD LECTURES FROM THE COTLOVE AND BENSON AWARDEES, PRESENTATIONS FROM THE YOUNG INVESTIGATOR AWARD WINNERS, THE YOUNG FACULTY AWARD WINNERS AND THE STRANDJORD GRANT AWARDEES, AND A POSTER SESSION. THE REGISTRATION FOR THIS MEETING WAS 700 FOR ACTIVE MEMBERS AND 525 FOR ASSOCIATE MEMBERS. THE COTLOVE AWARD WAS PRESENTED TO DR. WILBUR LAM WHO TALKED ABOUT "A PEDIATRICIAN'S ADVENTURES WITH POINT-OF-CARE TECHNOLOGIES IN THE LAB AND FOR THE NIH (AS WELL AS THE REST OF THE COUNTRY)". THE BENSON AWARD WAS PRESENTED TO DR. SIXTO LEAL WHO GAVE AN UPDATE ON "DIAGNOSTIC, TRANSLATIONAL, AND MECHANISTIC STUDIES IN INFECTIOUS DISEASE PATHOLOGY." THE ACADEMY ALSO CONTINUED THE PAUL E. STRANDJORD YOUNG INVESTIGATOR GRANT PROGRAM THIS YEAR AND PROVIDED TWO 7,500 RESEARCH GRANTS TO PROGRAM AWARDEES IN 2025. ACLPS HAD INITIATED A SERIES OF ARTICLES TITLED " ACLPS THE ESSENTIALS " PUBLISHED IN AJCP TO DISCUSS A CHALLENGING CONTEMPORARY TOPIC IN THE FIELD THROUGH A CASE-BASED FORMAT. IN ADDITION, AS A MEMBER OF THE RISE FIRST CLINICAL PATHOLOGY SECTION, ACLPS EDUCATION COMMITTEE EVALUATED QUESTIONS FOR THE CLINICAL PATHOLOGY PORTION OF THE EXAM. ACLPS CONTINUED TO SUPPORT CO-SPONSORED EDUCATIONAL SESSIONS AT THE ASCP ANNUAL MEETING. IT IS USUALLY A ONE-HOUR SESSION HIGHLIGHTING EDUCATIONAL TOPICS AND/OR INNOVATIVE RESEARCH IN THE FIELD OF LABORATORY MEDICINE. THE 2025 SPEAKER WAS ERIC Q KONNICK, MD WHO TALKED ABOUT TRANSFORMING CANCER CARE WITH CELL-FREE DNA TESTING. ACLPS CONTINUES TO PROVIDE EDUCATIONAL REVIEW ARTICLES FOR PUBLICATION IN THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY (AJCP).</Desc>
      <TotalProgramServiceExpensesAmt>59718</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc5">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc2">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc2">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc2">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc2">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc2">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc2">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc2">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc2">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc2">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc2">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc2">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc2">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc2">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc3">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc3">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>2</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>6</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>6</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>TATIANA YUZYUK PHD</PersonNm>
        <PhoneNum>8015832787</PhoneNum>
        <USAddress>
          <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
          <CityNm>SALT LAKE CITY</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>841081221</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>GRACE KRONER</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>S WESLEY LONG</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANGELLA CHARNOT-KASTIKAS MD</PersonNm>
        <TitleTxt>PAST PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN R GENZEN MD PHD</PersonNm>
        <TitleTxt>IMMEDIATE PA</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RON JACKUPS MD PHD</PersonNm>
        <TitleTxt>PRESIDENT EL</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TATIANA YUZYUK PHD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>6.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>1127</AllOtherContributionsAmt>
      <TotalContributionsAmt>1127</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>DUES</Desc>
        <TotalRevenueColumnAmt>44500</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>44500</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>44500</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>47390</TotalRevenueColumnAmt>
        <ExclusionAmt>47390</ExclusionAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>93017</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>44500</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>47390</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>15000</TotalAmt>
        <ProgramServicesAmt>15000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>2800</TotalAmt>
        <ProgramServicesAmt>2800</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>5750</TotalAmt>
        <ManagementAndGeneralAmt>5750</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>15</TotalAmt>
        <ProgramServicesAmt>15</ProgramServicesAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>2891</TotalAmt>
        <ProgramServicesAmt>2891</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>20032</TotalAmt>
        <ProgramServicesAmt>19365</ProgramServicesAmt>
        <ManagementAndGeneralAmt>667</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>14175</TotalAmt>
        <ProgramServicesAmt>14175</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <OtherExpensesGrp>
        <Desc>AJCP SUBSCRIPTION FEES</Desc>
        <TotalAmt>5000</TotalAmt>
        <ProgramServicesAmt>5000</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BANK CHARGES</Desc>
        <TotalAmt>1531</TotalAmt>
        <ManagementAndGeneralAmt>1531</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <TotalAmt>680</TotalAmt>
        <ManagementAndGeneralAmt>680</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>AWARDS</Desc>
        <TotalAmt>472</TotalAmt>
        <ProgramServicesAmt>472</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>10</TotalAmt>
        <ManagementAndGeneralAmt>10</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>68356</TotalAmt>
        <ProgramServicesAmt>59718</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8638</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>62054</BOYAmt>
        <EOYAmt>53728</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>25222</BOYAmt>
        <EOYAmt>26087</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>1599740</BOYAmt>
        <EOYAmt>1749108</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>1687016</BOYAmt>
        <EOYAmt>1828923</EOYAmt>
      </TotalAssetsGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1687016</BOYAmt>
        <EOYAmt>1828923</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>1687016</BOYAmt>
        <EOYAmt>1828923</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>1687016</BOYAmt>
        <EOYAmt>1828923</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>24661</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>117246</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc5">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>14975</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2813</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1150</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2154</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1127</CurrentTaxYearAmt>
        <TotalAmt>22219</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>43050</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>31219</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>40550</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>39450</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>44500</CurrentTaxYearAmt>
        <TotalAmt>198769</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>58025</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>34032</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>41700</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>41604</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>45627</CurrentTaxYearAmt>
        <TotalAmt>220988</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>220988</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>27408</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>33152</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>32322</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>40276</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>47390</CurrentTaxYearAmt>
        <TotalAmt>180548</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>27408</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>33152</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>32322</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>40276</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>47390</CurrentTaxYearAmt>
        <TotalAmt>180548</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>85433</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>67184</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>74022</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>81880</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>93017</CurrentTaxYearAmt>
        <TotalAmt>401536</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.55040</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.55310</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.45000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.43000</InvestmentIncomePYPct>
      <PrivateFoundation509Ind>X</PrivateFoundation509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc2">
      <TotalRevEtcAuditedFinclStmtAmt>210263</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>117246</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>117246</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>93017</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>93017</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>68356</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>68356</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>68356</TotalExpensesPerForm990Amt>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc3">
      <GrantRecordsMaintainedInd>false</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <CashGrantAmt>7500</CashGrantAmt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NEW YORK UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <CashGrantAmt>7500</CashGrantAmt>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>EACH YEAR, THE FOLLOWING AWARDS ARE GIVEN BY THE ORGANIZATION. COTLOVE LECTURESHIP: PRESENTED TO A SCIENTIST FOR OUTSTANDING CONTRIBUTIONS TO THE SCIENCE OF LABORATORY MEDICINE. GERLAD T. EVANS AWARD: PRESENTED TO A MEMBER OF THE ORGANIZATION TO RECOGNIZE OUTSTANDING LEADERSHIP OR SERVICE TO THE ORGANIZATION. ELLIS BENSON AWARD: PRESENTED TO A YOUNG FACULTY MEMBER IN RECOGNITION OF MERITORIOUS ACCOMPLISHMENT IN THE FIELD OF LABORATORY MEDICINE. PAUL E. STRANDJORD YOUNG INVESTIGATOR AWARD: AWARDED TO A RESIDENT, FELLOW, OR DOCTORAL STUDENT IN HEALTH SCIENCES DESIGNED TO ENCOURAGE THEM TO CONSIDER A CAREER IN ACADEMIC LABORATORY MEDICINE. YOUNG INVESTIGATOR GRANT PROGRAM: AWARDED FOR RESEARCH RELEVANT TO CLINICAL LABORATORY SCIENCE, CLINICAL PATHOLOGY, AND LABORATORY MEDICINE. PROPOSED RESEARCH MAY BE CLINICAL, TRANSLATIONAL, BASIC SCIENCE, QUALITY IMPROVEMENT, AND/OR REGULATORY. AS THIS GRANT PROGRAM IS DESIGNED FOR YOUNG INVESTIGATORS, GRANT RECIPIENTS MUST EITHER BE IN TRAINING (RESIDENCY AND/OR FELLOWSHIP) OR LESS THAN THREE YEARS AFTER THEIR FIRST FACULTY APPOINTMENT (ANY LEVEL) AT THE TIME OF APPLICATION. AWARDEES WILL BE EXPECTED TO PRESENT THEIR RESEARCH AT AN UPCOMING ACLPS ANNUAL MEETING. THE PURPOSE OF THE AWARDS IS TO PROMOTE INVOLVEMENT IN THE PROGRESS OF LABORATORY MEDICINE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc4">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>DURING THE YEAR THAT ENDED SEPTEMBER 30, 2025, THE ACADEMY PROVIDED SERVICES TO APPROXIMATELY 400 ACTIVE MEMBERS AND 220 ASSOCIATE MEMBERS. MORE THAN 200 INDIVIDUALS ATTENDED THE ACLPS ANNUAL MEETING ("LAB MEDICINE") IN ATLANTA, GA, ON MAY 29-31, 2025. THE MEETING WAS HOSTED BY EMORY UNIVERSITY. OVER THE THREE DAYS, CONFERENCE ATTENDEES ENJOYED SCIENTIFIC SESSIONS, THE AWARD LECTURES FROM THE COTLOVE AND BENSON AWARDEES, PRESENTATIONS FROM THE YOUNG INVESTIGATOR AWARD WINNERS, THE YOUNG FACULTY AWARD WINNERS AND THE STRANDJORD GRANT AWARDEES, AND A POSTER SESSION. THE REGISTRATION FOR THIS MEETING WAS 700 FOR ACTIVE MEMBERS AND 525 FOR ASSOCIATE MEMBERS. THE COTLOVE AWARD WAS PRESENTED TO DR. WILBUR LAM WHO TALKED ABOUT "A PEDIATRICIAN'S ADVENTURES WITH POINT-OF-CARE TECHNOLOGIES IN THE LAB AND FOR THE NIH (AS WELL AS THE REST OF THE COUNTRY)". THE BENSON AWARD WAS PRESENTED TO DR. SIXTO LEAL WHO GAVE AN UPDATE ON "DIAGNOSTIC, TRANSLATIONAL, AND MECHANISTIC STUDIES IN INFECTIOUS DISEASE PATHOLOGY." THE ACADEMY ALSO CONTINUED THE PAUL E. STRANDJORD YOUNG INVESTIGATOR GRANT PROGRAM THIS YEAR AND PROVIDED TWO 7,500 RESEARCH GRANTS TO PROGRAM AWARDEES IN 2025. ACLPS HAD INITIATED A SERIES OF ARTICLES TITLED " ACLPS THE ESSENTIALS " PUBLISHED IN AJCP TO DISCUSS A CHALLENGING CONTEMPORARY TOPIC IN THE FIELD THROUGH A CASE-BASED FORMAT. IN ADDITION, AS A MEMBER OF THE RISE FIRST CLINICAL PATHOLOGY SECTION, ACLPS EDUCATION COMMITTEE EVALUATED QUESTIONS FOR THE CLINICAL PATHOLOGY PORTION OF THE EXAM. ACLPS CONTINUED TO SUPPORT CO-SPONSORED EDUCATIONAL SESSIONS AT THE ASCP ANNUAL MEETING. IT IS USUALLY A ONE-HOUR SESSION HIGHLIGHTING EDUCATIONAL TOPICS AND/OR INNOVATIVE RESEARCH IN THE FIELD OF LABORATORY MEDICINE. THE 2025 SPEAKER WAS ERIC Q KONNICK, MD WHO TALKED ABOUT TRANSFORMING CANCER CARE WITH CELL-FREE DNA TESTING. ACLPS CONTINUES TO PROVIDE EDUCATIONAL REVIEW ARTICLES FOR PUBLICATION IN THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY (AJCP).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD OF DIRECTORS IS PROVIDED A DRAFT COPY OF THE FORM 990 TO REVIEW PRIOR TO FILING. THE BOARD CAN ASK QUESTIONS, REQUEST CLARIFICATION, AND MAKE ANY CHANGES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>